NanoEcho AB (publ) (FRA:XT4)

Market Cap	1.29M -35.5%
Revenue (ttm)	102.14K -93.3%
Net Income	-1.32M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0170
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About NanoEcho AB

NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2013
• Employees: 5
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XT4

Financial Performance

In 2025, NanoEcho AB's revenue was 487,000, a decrease of -93.30% compared to the previous year's 7.27 million. Losses were -15.65 million, 3.35% more than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error